Vir Biotechnology (VIR) Assets (2018 - 2026)
Vir Biotechnology (VIR) reported Assets of $1.21 billion for Q2 2026, up 1.9% from $1.19 billion a year earlier and up 18.5% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology posted Assets of $1 billion, down 28.3% from FY2024.
- Assets has declined for three consecutive years, though with a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- By year, Assets came in at $1.4 billion in FY2024 (-27.1%), $1.92 billion in FY2023 (-31.5%), $2.8 billion in FY2022 (+43.4%) and $1.95 billion in FY2021 (+112.7%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q1 2025.
- Year over year, Assets gained in 1 of the last eight quarters, with an average decline of 23.7%.
- The high point for year-over-year Assets in five years was Q1 2022 (growth of 154.2%); the low point was Q1 2024 (a decline of 32.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.03 billion (Q1 2026), $1 billion (Q4 2025) and $1.02 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 1.21 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 1.50 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.79 Bn |
| Dec 31, 2023 | 1.92 Bn |
| Sep 30, 2023 | 2.04 Bn |
| Jun 30, 2023 | 2.24 Bn |
| Mar 31, 2023 | 2.67 Bn |
| Dec 31, 2022 | 2.80 Bn |
| Sep 30, 2022 | 2.70 Bn |
| Jun 30, 2022 | 2.62 Bn |
| Mar 31, 2022 | 2.89 Bn |
| Dec 31, 2021 | 1.95 Bn |
| Sep 30, 2021 | 1.21 Bn |
API Access
Vir Biotechnology Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();